Out-of-Pocket Expenses and Their Burden in Patients With Rheumatoid Arthritis

被引:30
|
作者
Wolfe, Frederick [1 ,2 ]
Michaud, Kaleb [1 ,3 ]
机构
[1] Natl Data Bank Rheumat Dis, Wichita, KS 67214 USA
[2] Univ Kansas, Sch Med, Lawrence, KS 66045 USA
[3] Univ Nebraska Med Ctr, Omaha, NE USA
来源
关键词
HEALTH; COSTS; CARE; EXPENDITURES; PREDICTORS; EQ-5D;
D O I
10.1002/art.24724
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To describe and understand the burden of out-of-pocket expenses in patients with rheumatoid arthritis (RA). Methods. We studied out-of-pocket expenses and their burden in 8,545 US patients with RA. We determined direct medical costs, out-of-pocket expenses, the burden of out-of-pocket expenses, household income, and measures of RA severity and outcome. In addition, patients were classified into 3 groups based on the level of burden caused by out-of-pocket expenses: no or limited problem (I am able to pay the bills without much problem); moderate problem (paying the bills takes away some money I need for other activities); and a great problem (I can't purchase all of the medications or medical care that I need). Results. A total of 43.6% of patients reported problems paying medical bills after insurance payments and 9.0% reported severe or great problems. Problems with expenses were associated with measures of RA severity, but also and particularly with lower household income and absence of health insurance. The proportion of household income that was consumed by out-of-pocket spending for the 3 groups was 2.4%, 7.2%, and 19.2%, respectively, and the percentage of patients meeting the 185% poverty level for these groups was 12.3%, 24.4%, and 51.3%, respectively. Conclusion. The out-of-pocket burden is substantial, particularly in those <65 years of age. Out-of-pocket expenses exert their severity predominantly on those with the most severe RA who have the least ability to pay. Household income is the primary determinant of out-of-pocket burden, followed by RA severity, and type of health insurance.
引用
收藏
页码:1563 / 1570
页数:8
相关论文
共 50 条
  • [1] PATIENTS' OUT-OF-POCKET EXPENSES ANALYSIS IN PATIENTS WITH RHEUMATOID ARTHRITIS ENROLLED IN A EDUCATIONAL PROGRAM
    Buitrago-Garcia, D.
    Rodriguez, F.
    Sanchez, G.
    Santos-Moreno, P.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1954 - 1954
  • [2] Trends in out-of-pocket cost burden for rheumatoid arthritis patients.
    Curkendall, Suellen
    Nichol, Michael B.
    Dylan, Michelle
    Nordyke, Robert
    Patel, Vaishali
    Zagari, Martin
    Chiou, Chiun-Fang
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S113 - S113
  • [3] Association between out-of-pocket expenses and clinical outcomes, and quality of life in patients with rheumatoid arthritis
    Tang, B.
    Rahman, M., I
    Annunziata, K.
    Thompson, H.
    Naim, A.
    Freedman, D.
    [J]. VALUE IN HEALTH, 2008, 11 (03) : A262 - A262
  • [4] Methodological biases in estimating the burden of out-of-pocket expenses
    Goldman, DP
    Smith, JP
    [J]. HEALTH SERVICES RESEARCH, 2001, 35 (06) : 1357 - 1365
  • [5] Breast cancer patients' out-of-pocket expenses
    Moore, KA
    [J]. CANCER NURSING, 1999, 22 (05) : 389 - 396
  • [6] The Economic Burden of Out-of-Pocket Expenses for Plastic Surgery Procedures
    Billig, Jessica I.
    Chen, Jung-Sheng
    Lu, Yu-Ting
    Chung, Kevin C.
    Sears, Erika D.
    [J]. PLASTIC AND RECONSTRUCTIVE SURGERY, 2020, 145 (06) : 1541 - 1551
  • [7] Methodological biases in estimating the burden of out-of-pocket expenses - Reply
    Alecxih, L
    Corea, J
    Gross, D
    Caplan, C
    Brangan, N
    Gibson, MJ
    [J]. HEALTH SERVICES RESEARCH, 2001, 35 (06) : 1365 - 1370
  • [8] An Overdose of Out-of-Pocket Expenses
    Cohn, Jonathan
    [J]. MILBANK QUARTERLY, 2014, 92 (03): : 418 - 421
  • [9] Patient out-of-pocket expenses
    Aranda, Sanchia
    Whittaker, Kate
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 85 - 86
  • [10] Economic Burden of the Out-of-Pocket Expenses for People with Multiple Sclerosis in France
    Olivier Heinzlef
    Guillaume Molinier
    Benoît van Hille
    Lise Radoszycki
    Paul Dourgnon
    Juliette Longin
    [J]. PharmacoEconomics - Open, 2020, 4 : 593 - 603